Cranbrook Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3K | Hold |
1,313
| – | – | ﹤0.01% | 247 |
|
|
2025
Q1 | $19.5K | Hold |
1,313
| – | – | ﹤0.01% | 232 |
|
|
2024
Q4 | $17.4K | Hold |
1,313
| – | – | ﹤0.01% | 235 |
|
|
2024
Q3 | $18.7K | Hold |
1,313
| – | – | ﹤0.01% | 228 |
|
|
2024
Q2 | $17K | Hold |
1,313
| – | – | ﹤0.01% | 228 |
|
|
2024
Q1 | $18.2K | Hold |
1,313
| – | – | ﹤0.01% | 206 |
|
|
2023
Q4 | $18.7K | Hold |
1,313
| – | – | 0.01% | 204 |
|
|
2023
Q3 | $20.3K | Hold |
1,313
| – | – | 0.01% | 187 |
|
|
2023
Q2 | $20.6K | Hold |
1,313
| – | – | 0.01% | 194 |
|
|
2023
Q1 | $21.6K | Hold |
1,313
| – | – | 0.01% | 196 |
|
|
2022
Q4 | $20.5K | Hold |
1,313
| – | – | 0.01% | 194 |
|
|
2022
Q3 | $17K | Hold |
1,313
| – | – | ﹤0.01% | 219 |
|
|
2022
Q2 | $18K | Hold |
1,313
| – | – | ﹤0.01% | 220 |
|
|
2022
Q1 | $19K | Hold |
1,313
| – | – | ﹤0.01% | 244 |
|
|
2021
Q4 | $18K | Hold |
1,313
| – | – | ﹤0.01% | 245 |
|
|
2021
Q3 | $22K | Hold |
1,313
| – | – | 0.01% | 249 |
|
|
2021
Q2 | $22K | Hold |
1,313
| – | – | 0.01% | 236 |
|
|
2021
Q1 | $24K | Hold |
1,313
| – | – | 0.01% | 232 |
|
|
2020
Q4 | $24K | Hold |
1,313
| – | – | 0.01% | 197 |
|
|
2020
Q3 | $23K | Hold |
1,313
| – | – | 0.01% | 177 |
|
|
2020
Q2 | $24K | Hold |
1,313
| – | – | 0.01% | 170 |
|
|
2020
Q1 | $20K | Hold |
1,313
| – | – | 0.01% | 167 |
|
|
2019
Q4 | $26K | Hold |
1,313
| – | – | 0.01% | 167 |
|
|
2019
Q3 | $23K | Hold |
1,313
| – | – | 0.01% | 164 |
|
|
2019
Q2 | $23K | Hold |
1,313
| – | – | 0.01% | 162 |
|
|
2019
Q1 | $27K | Buy |
+1,313
| New | +$27K | 0.01% | 160 |
|